title: Re: Toth JM, Boden SD, Burkus JK, et al. Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environment. Spine 2009;34:539-50.
authors.forename: Tomislav
authors.initials: T
authors.lastname: Smoljanovic
authors.forename: Ivan
authors.initials: I
authors.lastname: Bojanic
authors.forename: Goran
authors.initials: G
authors.lastname: Bicanic
authors.forename: Domagoj
authors.initials: D
authors.lastname: Delimar
mesh_terms: D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000494:pharmacology*; D001862:Bone Resorption / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000494:pharmacology*; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
chemical_list: D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2